Cargando…
A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification
Heterotopic ossification (HO) occurs when bone forms within non-ossifying tissues, such as in muscle. Palovarotene, an activator of retinoic acid receptor γ (RAR-γ), has been shown to inhibit the formation of ectopic bone in HO model mice, but its specific mechanism of action remains unclear. This s...
Autores principales: | Huang, Junchao, Liu, Dachuan, Zhang, Jingwei, Xiao, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136101/ https://www.ncbi.nlm.nih.gov/pubmed/35646981 http://dx.doi.org/10.3389/fmed.2022.897392 |
Ejemplares similares
-
Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity
por: Lees-Shepard, John B, et al.
Publicado: (2018) -
Comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Pacifici, Maurizio, et al.
Publicado: (2019) -
Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Goldhamer, David J, et al.
Publicado: (2019) -
Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment
por: Huang, Junchao, et al.
Publicado: (2022) -
Macrophages in heterotopic ossification: from mechanisms to therapy
por: Huang, Yifei, et al.
Publicado: (2021)